StockWatch
·
Medical/Dental Instruments
Loan & DebtOct 22, 2026, 05:31 PM

Glucotrack Raises $2M Via Convertible Notes; Announces Reverse Stock Split

AI Summary

Glucotrack, Inc. has secured $2 million in financing through the issuance of senior secured convertible promissory notes with an aggregate principal amount of $2,564,102.65, reflecting a 22% original issue discount. The notes carry an 8% annual interest rate and mature in nine months, secured by company assets. Additionally, investors received warrants for 8.03 million shares. In a separate announcement, Glucotrack is implementing a 1-for-2 reverse stock split, effective October 26, 2026, to regain compliance with Nasdaq's minimum bid price requirement.

Key Highlights

  • Glucotrack, Inc. issued $2.56M in senior secured convertible notes for $2M cash, a 22% discount.
  • Notes bear 8% annual interest, mature in 9 months, and are secured by substantially all company assets.
  • Investors received warrants to purchase 8.03M shares of common stock at an exercise price of $1.5975.
  • The company announced a 1-for-2 reverse stock split effective October 26, 2026, to regain Nasdaq compliance.
  • The reverse stock split aims to increase the stock's bid price to meet Nasdaq's $1.00 minimum requirement.